PROMOTION SOFTWARE GMBH

Their core work

Promotion Software GmbH is a Tübingen-based software SME specialising in digital health applications for oncology and patient-centred care. Their core product work centres on patient-facing platforms that collect patient-reported outcomes, support self-management, and extend clinical monitoring beyond hospital walls. In both H2020 projects they functioned as the software development partner within research consortia, translating clinical requirements into deployable tools for cancer patients and their care teams. Their positioning sits at the intersection of health informatics and clinical research support, making them a practical bridge between research protocols and patient-usable technology.

What they specialise in

How they've shifted over time

In their first H2020 project (iManageCancer, 2015–2018) Promotion Software focused on general cancer self-management and patient empowerment, with no detailed keyword trail suggesting a broad platform-building role. By their second project (MyPal, 2019–2022) the focus had sharpened considerably — keywords point to specialised domains: early palliative care, haematologic malignancies, and formal patient-reported outcome systems. The trajectory is one of deepening clinical specialisation within oncology, moving from general empowerment tooling toward structured, protocol-grade PRO data collection for some of the most complex care pathways in cancer medicine.

Promotion Software is moving deeper into high-acuity oncology software — from broad patient empowerment toward specialised PRO tools for palliative and end-of-life care — suggesting future projects in precision symptom monitoring, digital companion apps for advanced cancer, or regulatory-grade clinical data collection.

How they like to work

Promotion Software operates exclusively as a consortium partner, never as coordinator, which is consistent with a specialist software vendor brought in to build and deliver a specific technical component rather than to lead a research agenda. With 22 partners across 8 countries over just 2 projects, they work within large, multi-national consortia typical of EU health research — indicating comfort with distributed teams and clinical partners from multiple health systems. This suggests they are accustomed to working under scientific leadership and adapting their software to diverse clinical and regulatory contexts.

Promotion Software has built a network of 22 consortium partners across 8 countries through two projects, a notably wide reach for a two-project portfolio and a sign that both consortia were large international collaborations. No repeated partner patterns are detectable from this dataset, suggesting they enter projects on technical merit rather than through a fixed network of recurring collaborators.

What sets them apart

Promotion Software occupies a rare niche as a software SME with demonstrated experience delivering patient-facing digital tools specifically within EU-funded clinical research consortia — a context that demands both technical reliability and adherence to research protocols, ethics requirements, and multi-site deployment constraints. Unlike larger health IT vendors, they are small enough to embed deeply in a research project and agile enough to adapt to evolving clinical requirements. For a consortium building a patient-empowerment or PRO component in an oncology or chronic disease proposal, they bring both the technical capability and the H2020 track record to reduce execution risk.

Highlights from their portfolio

• iManageCancer
  Their largest single-project EC award (€466,250) and the foundational project establishing their identity as a cancer patient empowerment software developer within EU research.
• MyPal
  Demonstrates strategic deepening into palliative care — one of the most clinically and ethically demanding application areas in digital health — covering both adult and paediatric cancer populations.